In March 2009 the governments that had met eleven years earlier at the Twentieth Special Session of the United Nations General Assembly (UNGASS) to endorse a Political Declaration on drugs, reviewed achievements regarding their stated goal of “eliminating or significantly reducing the illicit manufacture, marketing and trafficking of psychotropic substances” by the year 2008 (
UN General Assembly, 1998). The strategies adopted by the signatory countries to achieve this ambitious goal have in turn been framed by three major international drug treaties: the 1961 Single Convention on Narcotic Drugs (as amended by a 1972 protocol); the 1971 Convention on Psychotropic Substances; and the 1988 Convention Against Illicit Traffic in Narcotic Drugs. These Conventions emphasize an approach to tackling drug problems that focuses predominantly on law enforcement measures, giving priority to reducing the supply and use of drugs by means of their legal prohibition and punishments for people involved in the illicit drug trade, including those who possess drugs for personal use (
Elliot et al., 2005;
Levine, 2003). The Political Declaration on drugs endorsed by UNGASS in 2009 for the next ten years reaffirms the emphasis of the Declaration of 1998.
The effectiveness of global drug policies which place priority on drug control through law enforcement has long been questioned (
Westermeyer, 1976;
Seccombe, 1995;
Wolfe and Malinowska-Sempruch, 2004). Quite apart from prohibition policies failing to reach their primary goal in the face of the globalization of drug use, there is growing concern of their iatrongenic effects regarding the violation of human rights and the promotion of otherwise preventable health risk among affected populations (
Csete, 2007;
Csete and Wolfe, 2008;
Wolfe, 2004). This brings into focus the need for research which explores how economic and political institutions, whether globally, nationally or locally, reproduce social and economic conditions which shape health harm and inequalities (
Krieger, 2005,
2008;
Rhodes, 2009).
The criminal justice system is one of the most visible, and best documented, structural mechanisms perpetuating social suffering and health risk related to drug use (
Rhodes, 2009). There is a large literature linking policing practices, and fear of the criminal justice system, to iatrogenic drug use effects, including HIV, overdose, tuberculosis, bacterial infections, and violence (
Friedman et al., 2006;
Kerr et al., 2005;
Miller et al., 2008;
Rhodes et al., 2003,
2008;
Shannon et al., 2008a,
b;
Werb et al., 2008). Prisons constitute physical expressions of risk environment, including for HIV and tuberculosis, and like other forms of criminal justice intervention, disproportionately affect minority populations (
Bourgois, 2003;
Galea and Vlahov, 2002;
Lemelle, 2002).
Importantly, the iatrogenic effects of drug policies are indirect and direct. Policing practices targeting the vulnerable, for example, are institutionalized expressions of
social and
moral regulation, made manifest through everyday techniques of policing and community surveillance up to and including the use of excessive force (
Cooper et al., 2005;
Rhodes et al., 2008). Policing policies can reproduce, indeed reinforce, underlying social injustices, fears and inequalities. As such they can combine with other forces of structural violence to sustain environments of risk and social suffering (
Rhodes, 2009). Structural violence is distinct from personal or direct violence in that it is embedded in
social structures, whereby “unequal power” shapes “unequal life chances” (
Galtung, 1990: 291). Poverty, racism and gender inequalities provide examples. Each of these perpetuate constraints in agency, leading to unequal opportunity and disproportionate social suffering for the marginalized (
Farmer, 2005). Crucially, the institutionalization, and everyday internalization, of structural violence can render it invisible (
Scheper-Hughes, 1996;
Farmer et al., 1996).
Singer (2004) links structural violence to “oppression illness” which he defines as the “product of the impact of suffering from social mistreatment”, a type of “stress disorder”, resulting from an oppressive social environment, whereby the everyday effects of structural violence are internalized. Structural violence is thus embodied through oppression illness (
Krieger, 2008), perpetuating health risk and inequality indirectly, through diminished self efficacy, self-blame, fear and anxiety, tempered expectations, fatalism, and ‘risk behaviour’ (
Singer, 2004; Rhodes et al., 2005). Drug use, itself, can be seen as a form of “self-medication” for oppression illness, providing “pain intolerance”, “chemical intervention” and a “solution” (
Singer, 2001). A growing body of epidemiological evidence corroborates the use of drugs, including risky drug use, as a response to social discrimination and social stress in high risk environments, including those linked to terror (
Vlahov et al., 2004;
Richman et al., 2008;
Gee et al., 2007; Siapush et al., 2008;
Peretti-Watel., et al., 2009).
While nation states have some autonomy in their interpretation and execution of drug policy as framed by the international Conventions, in Russia there is a history of state sponsored repression of individual rights, as well as a strong emphasis on law enforcement as a mechanism of social control, and a strong under-current of state surveillance (
Applebaum, 2003;
Lipman, 2005). The science and practice of drug treatment in Russia –
narcology – developed out of psychiatry in close collaboration with other state mechanisms of social control, including police agencies (
Elovich and Drucker, 2008). Close links between narcology and police agencies remain (
Bobrova et al., 2006). Access to drug treatment automatically requires official registration as an addict, which involves the removal of various citizenship rights, such as the rights to employment, as well as exposure to social stigma (
Bobrova et al., 2006). The effectiveness of drug treatment approaches (which are modelled on alcohol detoxification methods) remain questionable, are linked to high rates of relapse, and are framed by a policy response at Federal level which prohibits the use of (internationally accepted) methadone and buprenorphine as substitution treatment (
Elovich and Drucker, 2008;
Mendelevich, 2004;
Human Rights Watch, 2007). This policy rests on the rationale that treating addicts as patients would challenge policy discourse that labels drug users first and foremost as “criminals” (
Elovich and Drucker, 2008).
Street-level policing practices in Russia have been found to fuel a pervasive sense of risk, and fear of arrest, fine or detainment, among IDUs, which in turn is linked to their reluctance to carry needles and syringes, thereby increasing the chances of high risk syringe sharing at the point of drug sale (
Rhodes et al., 2003). Police agencies themselves emphasise a rationale of intense surveillance of drug users, enforced through a combination of extremely restrictive criminal articles on possession and the use of administrative codes unrelated to drug use (
Rhodes et al., 2003,
2006). Moreover, civil society responses to HIV prevention, treatment and care for IDUs remain weak, as does public health policy and infrastructure, which depends heavily upon international donation (
Sarang et al., 2007;
Wolfe, 2007). Officials and health professionals give very weak endorsement to concepts such as ‘harm reduction’, which are still characterised by some as a corrupting influence of the West, and instead defer to normative social constructions of drugs users as unproductive, dangerous, and criminal (Tkathchenko-Schmidt et al., 2008;
Elovich and Drucker, 2008;
Wolfe, 2007).
Taken together, an overarching emphasis on law enforcement at the expense of public health approaches may promote a risk environment enabling HIV risk while violating human rights to health. These violations are made possible by the promotion, at Federal level and below, of excessively severe legal restrictions surrounding drug possession and use. This anti-drug legal environment combines with the relative autonomy of law enforcement agencies to practice ‘law off the books’ (
Burris et al., 2004) and the lax enforcemnt of of anti-corruption legislation. Human rights organisations have characterised drug policy in Russia primarily in terms of its criminalisation, stigmatisation and dehumanisation of people who use drugs (
Human Rights Watch, 2004,
2007). This is in a context of one of the largest epidemics of HIV associated with drug injecting, continued HIV transmission among IDUs, and large population estimates of IDUs (
Platt et al., 2004;
Dolzhanskaya, 2006;
Laetitia et al., 2000;
Rhodes et al., 1999).